Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $202,331 - $229,404
4,217 New
4,217 $229,000
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $700 - $778
11 Added 0.33%
3,394 $217,000
Q1 2023

May 03, 2023

SELL
$65.71 - $74.53 $33,380 - $37,861
-508 Reduced 13.06%
3,383 $234,000
Q3 2022

Nov 15, 2022

SELL
$0.13 - $76.84 $57 - $34,270
-446 Reduced 10.28%
3,891 $276,000
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $24,472 - $26,953
-337 Reduced 7.21%
4,337 $334,000
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $3,319 - $3,980
54 Added 1.17%
4,674 $341,000
Q4 2021

Feb 15, 2022

SELL
$53.63 - $62.52 $39,954 - $46,577
-745 Reduced 13.89%
4,620 $288,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $49,584 - $58,081
-838 Reduced 13.51%
5,365 $317,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $25.2 Million - $27.5 Million
407,632 Added 5927.47%
414,509 $6.2 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $25.3 Million - $27.5 Million
-408,306 Reduced 98.5%
6,203 $415,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $110,283 - $124,971
1,910 Added 38.45%
6,877 $427,000
Q3 2020

Nov 05, 2020

BUY
$57.43 - $63.64 $36,582 - $40,538
637 Added 14.71%
4,967 $299,000
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $7,455 - $8,716
-136 Reduced 3.05%
4,330 $255,000
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $9,140 - $13,283
-197 Reduced 4.22%
4,466 $249,000
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $56,099 - $73,176
1,140 Added 32.36%
4,663 $299,000
Q3 2019

Oct 30, 2019

SELL
$42.77 - $50.71 $78,867 - $93,509
-1,844 Reduced 34.36%
3,523 $179,000
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $86,250 - $95,374
1,933 Added 56.29%
5,367 $243,000
Q1 2019

Apr 18, 2019

BUY
$45.12 - $53.8 $3,564 - $4,250
79 Added 2.35%
3,434 $163,000
Q4 2018

Mar 26, 2019

BUY
$48.76 - $63.23 $163,589 - $212,136
3,355 New
3,355 $174,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.